These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Vitamin D insufficiency and treatment with oral vitamin D3 in children with chronic kidney disease. Kari JA, Eldesoky SM, Bagdadi OT. Saudi Med J; 2012 Jul; 33(7):740-4. PubMed ID: 22821307 [Abstract] [Full Text] [Related]
31. Serum 25-hydroxyvitamin D3, parathyroid hormone and blood pressure in an elderly cohort from Germany: a cross-sectional study. Jungert A, Roth HJ, Neuhäuser-Berthold M. Nutr Metab (Lond); 2012 Mar 21; 9(1):20. PubMed ID: 22433818 [Abstract] [Full Text] [Related]
32. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients. Ulusoy S, Ozkan G, Guvercin B, Yavuz A. Artif Organs; 2016 Nov 21; 40(11):1078-1085. PubMed ID: 27110947 [Abstract] [Full Text] [Related]
33. Serum cystatin C and left ventricular diastolic dysfunction in children with chronic kidney disease. Mitsnefes M, Kimbal T, Kartal J, Kathman T, Mishra J, Devarajan P. Pediatr Nephrol; 2006 Sep 21; 21(9):1293-8. PubMed ID: 16721586 [Abstract] [Full Text] [Related]
34. Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease. Patange AR, Valentini RP, Du W, Pettersen MD. Pediatr Cardiol; 2012 Jan 21; 33(1):122-8. PubMed ID: 21912948 [Abstract] [Full Text] [Related]
35. Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects. Asp AM, Wallquist C, Rickenlund A, Hylander B, Jacobson SH, Caidahl K, Eriksson MJ. Clin Physiol Funct Imaging; 2015 May 21; 35(3):223-30. PubMed ID: 24750894 [Abstract] [Full Text] [Related]
36. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications. Pareek M. Dan Med J; 2017 Sep 21; 64(9):. PubMed ID: 28874244 [Abstract] [Full Text] [Related]
37. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease]. Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA. Ter Arkh; 2015 Sep 21; 87(6):10-16. PubMed ID: 26281189 [Abstract] [Full Text] [Related]
38. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease. Parker VJ, Harjes LM, Dembek K, Young GS, Chew DJ, Toribio RE. J Vet Intern Med; 2017 May 21; 31(3):791-798. PubMed ID: 28186657 [Abstract] [Full Text] [Related]
39. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. Mitsnefes MM, Kimball TR, Kartal J, Witt SA, Glascock BJ, Khoury PR, Daniels SR. J Pediatr; 2006 Nov 21; 149(5):671-5. PubMed ID: 17095341 [Abstract] [Full Text] [Related]
40. Cross-sectional Study of Calcium Phosphate Product and Intact Parathyroid Hormone Levels in Predialysis and Postdialysis Patients with Stage 5 Chronic Kidney Disease. Rastogi A, Kumar S, Kumar R, Singh AK, Kumar C, Prakash G. Saudi J Kidney Dis Transpl; 2021 Nov 21; 32(4):967-972. PubMed ID: 35229793 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]